Resistance to Recombinant Interferon Alfa-2a in Hairy-Cell Leukemia Associated with Neutralizing Anti-Interferon Antibodies
Ronald G. Steis, Dan L. Longo(Harvard University), John W. Smith(SUNY Upstate Medical University), Loretta M. Itri(National Institutes of Health), Jeffrey W. Clark(Massachusetts General Hospital), Lydia M. Evans(La Roche College), Carolyn Schoenberger(Calvert Memorial Hospital), Walter J. Urba(Providence Portland Medical Center)
Cited by 246
Related Papers
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2014|2k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
<i>ROS1</i> Rearrangements Define a Unique Molecular Class of Lung Cancers
|Journal of Clinical Oncology|2012|1.6k